• ebola
    35
    0

    Oct 18, 2021 Three new Ebola cases have been confirmed in eastern Democratic Republic of Congo, bringing the total to five in the last 10 days, the World Health Organization (WHO) said on Monday. Health officials have said the latest flare-up of the virus appeared to be linked to the massive 2018-20 outbreak, which killed ...
  • ebola
    40
    0

    Sept. 14, 2021 Johnson & Johnson says its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. The two-dose regimen was well-tolerated and induced antibody responses to the Zaire ebolavirus species 21 days after the second dose in 98% of all participants, the company ...
  • database
    53
    0

    August 16, 2021 The Federal Government on Monday commenced the administration of new vaccines marking the start of the second phase of the COVID-19 vaccination programme. This is coming days after the US donated over four million doses of the Moderna vaccine to the country. Only about one percent of the population has been fully ...
  • lives and livelihoods
    61
    0

    August 10, 2021 Nigeria is expected to receive 176,000 doses of the Johnson and Johnson COVID-19 vaccines on Wednesday. Executive Director, National Primary Health Care Development Agency, Faisal Shuaib, confirmed this at a news conference in Abuja on Tuesday. He said the J&J vaccine, like the AstraZeneca, is safe and efficient against the coronavirus disease, ...
  • countries
    77
    0

    June 25, 2021 South Africa aims to more than double the rate of daily COVID-19 vaccinations over the next month to more than 200,000 as more Pfizer and Johnson & Johnson shots arrive, health officials said on Friday. The country’s vaccination campaign has started slowly, set back by the revelation that AstraZeneca’s vaccine is much ...
  • lives and livelihoods
    91
    0

    May 18, 2021 The National Agency for Food, Drug Administration and Control (NAFDAC) says it has granted conditional Emergency Use Authorisation for Johnson and Johnson (J&J) Vaccine to prevent COVID-19. Information on the approval for J & J, also known as Janssen Vaccine, is in a statement signed by the Director General of the agency, ...
  • countries
    114
    0

    Up to 400 million doses of Johnson & Johnson’s Covid-19 vaccine will be made available to African countries, the US pharmaceutical giant said Monday. The availability of the single-shot vaccine will be subject to national regulatory approvals in the African Union’s 55 member states, with the first shipments expected to arrive in the third quarter ...
  • 117
    0

    Johnson & Johnson’s single-shot Covid-19 vaccine has an overall efficacy of 66 percent, the company announced Friday, following results from a phase 3 trial of almost 44,000 people across many countries. The figure however was as high as 72 percent in the United States but went down to 57 percent in South Africa, where a ...
  • infection
    385
    0

    Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side effects, the drugmakers said on Wednesday. The vaccine’s efficacy was found to be consistent across different ages and ethnicities – a promising sign ...
  • vaccines
    266
    0

    Johnson & Johnson launched a new large-scale late-stage trial on Monday to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental benefits for the duration of protection with a second dose. The U.S. drugmaker plans to enrol up to 30,000 participants for the study and run it in parallel with a ...